D89.835 Cytokine release syndrome, grade 5

Name of the Condition

• Cytokine release syndrome, grade 5

Summary

Cytokine release syndrome (CRS), grade 5, is the most severe form of an immune-mediated condition characterized by excessive cytokine release, leading to life-threatening systemic inflammation and multi-organ failure. This grade represents the highest level of clinical severity, with profound hypotension, respiratory failure, and other critical organ dysfunction. CRS can occur in response to infections, immunotherapies, or other immune-stimulating triggers, with severity graded based on clinical presentation.

Causes

CRS is triggered by the overactivation of immune cells, which release large amounts of cytokines into the bloodstream. Common triggers include immunotherapies (e.g., chimeric antigen receptor T-cell therapy), severe infections, or medications that stimulate immune responses. The exact mechanism involves immune cell activation leading to a cytokine cascade, with grade 5 representing the most severe form of this response.

Risk Factors

• Exposure to immune-stimulating therapies (e.g., immunotherapy)
• Severe infections or sepsis
• Pre-existing immune dysregulation
• High cytokine levels from prior immune activation
• Certain genetic predispositions to inflammatory responses

Symptoms

• Profound hypotension (life-threatening low blood pressure)
• Respiratory failure requiring mechanical ventilation
• Multi-organ failure (e.g., renal, hepatic, cardiac)
• Severe tachycardia or bradycardia
• Altered mental status or coma
• Disseminated intravascular coagulation (DIC)

Diagnosis

Diagnosis of CRS grade 5 is based on clinical presentation, including severe hypotension, respiratory failure, and multi-organ dysfunction, often confirmed by elevated cytokine levels and exclusion of other causes. Clinical criteria for grading (e.g., ASTCT consensus) are used to assess severity. Laboratory tests may show elevated inflammatory markers, and imaging or organ function tests support organ involvement.

Treatment Options

Treatment focuses on aggressive supportive care, including vasopressors for hypotension, mechanical ventilation for respiratory failure, and organ support (e.g., dialysis for renal failure). Immunosuppressive therapies (e.g., tocilizumab, corticosteroids) may be used to mitigate cytokine release. Management is multidisciplinary, involving intensive care and targeted interventions based on organ involvement.

Prognosis and Follow-Up

Prognosis for CRS grade 5 is poor, with high mortality risk due to multi-organ failure. Survivors require close monitoring for long-term organ damage and immune recovery. Follow-up includes regular assessments of organ function, immune status, and management of sequelae. Early intervention and intensive care improve outcomes, but recovery depends on the extent of organ damage.

Complications

• Multi-organ failure (renal, hepatic, cardiac)
• Persistent immune dysregulation
• Long-term organ dysfunction (e.g., chronic kidney disease)
• Increased susceptibility to infections
• Thrombotic events (e.g., pulmonary embolism)

Lifestyle & Prevention

Prevention focuses on risk stratification before immune-stimulating therapies, prophylactic measures (e.g., premedication), and close monitoring during treatment. Lifestyle modifications are limited but may include managing underlying conditions (e.g., infections) and adhering to therapy protocols. Prompt recognition of early symptoms is critical to prevent progression to severe grades.

When to Seek Professional Help

Seek immediate medical attention for symptoms of severe hypotension, respiratory distress, or altered mental status, especially after immune-stimulating therapies or infections. Early intervention is vital to prevent progression to life-threatening organ failure.

Tips for Medical Coders

Code D89.835 is assigned for documented cytokine release syndrome, grade 5. Ensure clinical documentation specifies the grade and confirms severe organ involvement (e.g., respiratory failure, multi-organ dysfunction). Verify that the diagnosis aligns with established grading criteria (e.g., ASTCT) and exclude other causes of similar symptoms. Document the trigger (e.g., immunotherapy, infection) if available, as it may impact coding context.